An observational study on safety profile of ofloxacin and levofloxacin in treatment of acute exacerbation of chronic bronchitis
Journal Title: International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP) - Year 2019, Vol 8, Issue 2
Abstract
Background COPD is predicted to be the third most common cause of death and chronic disability in the world by 2020. The term COPD encompasses several conditions. These include airflow obstruction with little reversibility, chronic bronchitis, emphysema, and small airways disease. Outcomes when hospitalized are poor, with 34% being re-admitted and 14% dying within 3 months. Aims and objectives To monitor, evaluate and compare the adverse effect profile of Ofloxacin and Ciprofloxacin in acute exacerbation of chronic bronchitis. Methods This was a prospective, observational study done in 200 patients of clinically diagnosed acute bronchitis in the department of pulmonology, SMC/GGH, Vijayawada. Newly diagnosed 200patients of acute bronchitis (from January 2017 to June 2017), pulmonology outpatient department, GGH, SMC, VJA of age 18–65 years of either gender who were prescribed either Levofloxacin (n = 100) or ofloxacin (OZP group, n = 100) and who gave written informed consent were enrolled. One group of the patients received Tab. Ofloxacin 400 mg BD and other group received Tab. Levofloxacin 500 mg OD for 7 days. The study duration was 6 months. Results In Ofloxacin group 63 patients reported ADRs out of which 40 are male and 23 are female. In Levofloxacin group, 19 patients reported ADR, of which 10 were men and 09 women (figure 1). Out of 63 ADRs in ofloxacin group 50 patients reported ADRs associated with CNS, 11patients reported ADRs associated with GIT & 02were associated with skin and its appendages. Out of 19 ADRs in levofloxacin group 10 patients reported ADRs associated with CNS, 08 patients reported ADRs associated with GIT & 01were associated with skin and its appendages (figure 2). Conclusion Even though, fluoroquinolones have excellent efficacy profile there are concerns about their safety. The present study concluded that no serious ADRs noted in both groups. But ofloxacin group of patients have shown increased incidence of ADRs associated with CNS especially Insomnia.
Authors and Affiliations
K Sankar
Keywords
Related Articles
- EP ID EP648128
- DOI -
- Views 63
- Downloads 0
Effects of Vitamin D on Blood Pressure: Vitamin D act as Anti Hypertensive agent
Aim The purpose of this study to rule out the role of vitamin D in hypertensive patients. Methodology Total 100 hypertensive patients were selected with same age and same disease criteria, they were divided in to two g...
Role Of Clinical Pharmacist In Identifying The Factors That Influence Medication Non- Adherence And Improvement On Hospitalised Geriatric Non-Adherent Patients
Background- Poor adherence is one of the major factors which alters therapeutic outcome of medication in geriatric patients with chronological diseases. Medication non-adherence is one of the drug related barrier for h...
An overview of Depression and its Pharmacotherapy
Depression is a very common mental health disorder, increasing with the socioeconomic and medical condition. Patients experience different feelings, depending upon the severity, frequency, and duration of symptoms. If l...
GC-MS Analysis and antimicrobial activity of essential oil of Nepeta coerulescens
The chemical composition of the essential oil obtained from the leaves of Nepeta coerulescens collected from the Zanskar sub district of Kashmir, was analyzed by GC-MS. The major constituent terpene hydrocarbon was foun...
Drug utilization study in urinary tract infection in a tertiary care hospital: a prospective study
Introduction Urinary tract infection (UTI) is one of the most common infections in outpatients setting as well as in acute and long term care hospital patients. Successful treatment and prevention of recurrence of UTI r...